Fusion Antibodies is a CRO that offers a range of antibody engineering services for all stages of therapeutic and diagnostic antibody development.
Latest News
- Year-end trading statement
05 May 2026 - Antibody IP transfer agreement
30 March 2026 - Director/PDMR Shareholding
17 February 2026
Investor Alert
Sign up for Investor Alerts »
